Skip to main content

Table 4 Changes in chitotriosidase activity between basal and follow-up sampling, in relation to subjective symptoms and therapy adjustments during the observation period

From: Chitotriosidase: a biomarker of activity and severity in patients with sarcoidosis

 Δ Chitotriosidase (nmol/ml/h)p-value
Therapy modification
 • Improved (n = 47)−64.5 ± 118.10.2045
 • Stable (n = 164)−1.3 ± 214.40.9389
 • Worsened (n = 215)44.1 ± 131.40.0012